REFRACTORY ANGINA
Clinical trials for REFRACTORY ANGINA explained in plain language.
Never miss a new study
Get alerted when new REFRACTORY ANGINA trials appear
Sign up with your email to follow new studies for REFRACTORY ANGINA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Heart patients' own cells may ease crippling chest pain
Disease control OngoingThis study tests whether a patient's own bone marrow cells can help people with severe chest pain that doesn't improve with standard treatments. About 343 adults with chronic heart pain will either receive the cell therapy or a sham procedure. The main goal is to see if the treat…
Matched conditions: REFRACTORY ANGINA
Phase: NA • Sponsor: BioCardia, Inc. • Aim: Disease control
Last updated May 26, 2026 11:04 UTC
-
Angina drug trial pulled before it even started
Symptom relief TerminatedThis study was designed to test a new drug, IMB-1018972, in people with refractory angina—chest pain that doesn't improve with standard treatments. The goal was to see if the drug could safely help patients exercise longer and have fewer angina episodes. However, the trial was wi…
Matched conditions: REFRACTORY ANGINA
Phase: PHASE2 • Sponsor: Imbria Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated May 26, 2026 11:06 UTC